S Bar-Meir

The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful

Shomron Ben‐Horin, Miri Yavzori, Lior H. Katz et al. · Gut · 2010 · 205 citations

Life Sciences, Immunology, Clinical Immunology +15

Risk Factors for Mortality in Patients Undergoing Percutaneous Endoscopic Gastrostomy

A. Lang, E. Bardan, Yehuda Chowers et al. · Endoscopy · 2004 · 96 citations

Medicine, Clinical Sciences, Surgery +14

Risk Factors Regarding the Need for a Second Operation in Patients with Crohn’s Disease

Benjamin Avidan, Emad Sakhnini, Adi Lahat et al. · Digestion · 2005 · 77 citations

Medicine, Clinical Sciences, Surgery +16